Lukas Biomedical Inc. (TPEX:6814)
Taiwan · Delayed Price · Currency is TWD 19.85
-1.65 (-7.67%)
Aug 26, 2026, 1:51 PM CST
Lukas Biomedical Market Cap
Lukas Biomedical has a market cap or net worth of 900.3 million as of August 26, 2026. Its market cap has decreased by -15.69% in one year.
Market Cap
900.30M
Enterprise Value
1.12B
Revenue
170.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.85
ChartMarket Cap Chart
Since December 31, 2020, Lukas Biomedical's market cap has decreased from 1.78B to 900.30M, a decrease of -49.29%. That is a compound annual growth rate of -11.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 1.03B | -20.81% |
| Dec 31, 2025 | 1.30B | 3.85% |
| Dec 31, 2024 | 1.25B | 15.69% |
| Dec 29, 2023 | 1.08B | -6.98% |
| Dec 30, 2022 | 1.16B | -15.47% |
| Dec 30, 2021 | 1.37B | -22.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| U-Neuron Biomedical | 1.15B |
| LabTurbo Biotech | 1.12B |
| BiOptic | 1.12B |
| Bio Preventive Medicine | 1.09B |
| Level Biotechnology | 1.02B |
| GeneReach Biotechnology | 979.88M |
| TCI GENE | 899.59M |
| Meribank Biotech | 888.74M |